Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.
Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.
Clin Exp Ophthalmol. 2018 Apr;46(3):260-265. doi: 10.1111/ceo.13031. Epub 2017 Aug 25.
In Australia, knowledge of the epidemiology of retinal vein occlusion remains scarce because of a paucity of recent population-based data. The National Eye Health Survey (2015-2016) provides an up-to-date estimate of the prevalence of retinal vein occlusion in non-Indigenous and Indigenous Australian adults.
To determine the prevalence and associations of retinal vein occlusion in a national sample of Indigenous and non-Indigenous Australian adults.
Population-based cross-sectional study.
A total of 3098 non-Indigenous Australians (aged 50-98 years) and 1738 Indigenous Australians (aged 40-92 years) living in 30 randomly selected sites, stratified by remoteness.
Retinal vein occlusions were graded from retinal photographs using standardized protocols and recorded as central retinal vein occlusion or branch retinal vein occlusion.
Prevalence of retinal vein occlusion.
In the non-Indigenous population, the sampling weight adjusted prevalence of any retinal vein occlusion was 0.96% (95% confidence interval: 0.59, 1.6), with branch retinal vein occlusion observed in 0.72% (95% confidence interval: 0.41, 1.2) and central retinal vein occlusion in 0.24% (95% confidence interval: 0.13, 0.47). Any retinal vein occlusion was found in 0.91% (95% confidence interval: 0.47, 1.7) of Indigenous Australians aged 40 years and over, with branch retinal vein occlusion observed in 0.83% (95% confidence interval: 0.40, 1.7) and central retinal vein occlusion in 0.07% (95% confidence interval: 0.02, 0.32). Older age (odds ratio = 1.64 per 10 years, P = 0.006) and the presence of self-reported diabetes (odds ratio = 3.24, P = 0.006) were associated with any retinal vein occlusion after multivariable adjustments. Retinal vein occlusion was attributed as the cause of monocular vision loss (<6/12) in seven (0.25%) non-Indigenous and six (0.36%) Indigenous participants.
These data suggest that retinal vein occlusion is relatively uncommon in the non-Indigenous Australians aged 50 years and over and Indigenous Australians aged 40 years and over. Similar to previous Australian and international reports, the prevalence of retinal vein occlusion rose sharply with age.
在澳大利亚,由于缺乏最近的基于人群的数据,视网膜静脉阻塞的流行病学知识仍然很少。国家眼健康调查(2015-2016 年)提供了非原住民和澳大利亚原住民成年人视网膜静脉阻塞的最新患病率估计。
在全国样本的非原住民和原住民澳大利亚成年人中,确定视网膜静脉阻塞的患病率及其相关性。
基于人群的横断面研究。
共有 3098 名非原住民澳大利亚人(年龄 50-98 岁)和 1738 名原住民澳大利亚人(年龄 40-92 岁),居住在 30 个随机选择的地点,按偏远程度分层。
使用标准化协议从视网膜照片中分级视网膜静脉阻塞,并记录为中央视网膜静脉阻塞或分支视网膜静脉阻塞。
视网膜静脉阻塞的患病率。
在非原住民人群中,抽样权重调整后的任何视网膜静脉阻塞患病率为 0.96%(95%置信区间:0.59,1.6),分支视网膜静脉阻塞为 0.72%(95%置信区间:0.41,1.2),中央视网膜静脉阻塞为 0.24%(95%置信区间:0.13,0.47)。任何视网膜静脉阻塞在年龄在 40 岁及以上的原住民澳大利亚人中的患病率为 0.91%(95%置信区间:0.47,1.7),分支视网膜静脉阻塞为 0.83%(95%置信区间:0.40,1.7),中央视网膜静脉阻塞为 0.07%(95%置信区间:0.02,0.32)。年龄较大(每增加 10 岁,优势比为 1.64,P=0.006)和报告有糖尿病(优势比为 3.24,P=0.006)与多变量调整后的任何视网膜静脉阻塞相关。视网膜静脉阻塞被归因于 7 名(0.25%)非原住民和 6 名(0.36%)原住民参与者单眼视力丧失(<6/12)的原因。
这些数据表明,视网膜静脉阻塞在年龄在 50 岁及以上的非原住民澳大利亚人和年龄在 40 岁及以上的原住民澳大利亚人中相对罕见。与之前的澳大利亚和国际报告类似,视网膜静脉阻塞的患病率随年龄急剧上升。